ACT

APR. 26/2016

Advertisment

news roundup

BMS Selects Medidata Clinical Cloud

Bristol-Myers Squibb will integrate a full suite of Medidata solutions into all stages of its drug development process.


advertisment

From eligibility to exploratory: Planning and implementing biomarker testing for Immuno-oncology trials
Live webinar: Wednesday, April 27, 2016 11 am EDT (8 am PST)
Register here>>


Bracket Updates Platforms with SMS

Bracket announced platform updates to its eCOA and RTSM products to include support for text messaging with patients.

advertisment

Immuno-Oncology Insights:
Top 5 Challenges in Today's Immuno-Oncology Trials

On Demand
click here


Bioclinica, Aris Global Partner on PV

Bioclinica announced the selection of ArisGlobal's Safety Cloud as a platform for its pharmacovigilance services.


advertisment

Overcoming regulatory and statistical hurdles of biosimilars drug development
Designing smarter trials

On Demand
click here


ICN Adopts Clinerion’s Patient Recruitment System

The International Clinical Trial Center Network (ICN), a collection of academic and government-based research institutions, adopts Clinerion solution.

In this edition

BMS Selects Medidata Clinical Cloud
Interexpert Agreement on Adverse Events' Evaluation
Orphans Under Attack Again
Oncology--Imagining the Impossible: Immunity to Cancer

advertisment

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Events

eSource Data in Clinical Investigations Summit, Next Week
Fifth Annual Clinical Trial Innovation Summit
Search more events

Advertisment

Oncology

Imagining the Impossible: Immunity to Cancer

This article explores five challenges smaller biopharmaceutical companies should prepare for when embarking on immunotherapy studies.


Changing Regulatory Landscape for Orphan Drugs

In an orphan drug trial, clinical management of individual patients can be difficult. Understanding the burden of disease and managing patient and family experience within a study is key.


Precision Medicine Deserves Precision Trial Optimization

Just as we’re moving away from blockbuster drugs to “personal” and “precision” medicine, we need to move to “precision trial optimization.”

Articles

Interexpert Agreement on Adverse Events’ Evaluation

Our study confirmed that the overall agreement between clinical investigators and drug safety experts is low. Disagreements between experts may be due to different clinical background, perspective, and expertise.


Blog Posts

Orphans Under Attack Again

"The industry now sometimes makes undesirable use or even misuse of these protection mechanisms in order to maximize profit on a product."


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Watch ACT TV for interviews with
Clinical Trials Experts


Ask the editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com

Advertise

Mike Tessalone
Publisher
mtessalone@advanstar.com